<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-KYQQQIFC</identifier><date>2022</date><creator>Božić, Mićo</creator><creator>Mesti, Tanja</creator><relation>documents/doc/K/URN_NBN_SI_doc-KYQQQIFC_001.pdf</relation><relation>documents/doc/K/URN_NBN_SI_doc-KYQQQIFC_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 98-101</format><identifier identifier_type="COBISSID_HOST">137980931</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-KYQQQIFC</identifier><language>slv</language><publisher publisher_location="Ljubljana">Katedra za onkologijo</publisher><publisher publisher_location="Ljubljana">Onkološki inštitut</publisher><publisher publisher_location="Ljubljana">Sekcija za internistično onkologijo</publisher><source>Dnevi internistične onkologije 2022</source><rights>InC</rights><subject language_type_id="slv">bolniki</subject><subject language_type_id="slv">neželeni učinki</subject><subject language_type_id="slv">sistemsko zdravljenje</subject><title>Cutaneous toxicity of systemic anticancer therapies – report of two clinical cases</title><title>Kožna toksičnosti sistemskega zdravljenja raka – prikaz dveh kliničnih primerov</title></Record>